Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning

Early this year, a medical journal article caught the attention of cancer patients and doctors worldwide because of its extraordinary conclusion. Simply changing the time of day that immunotherapy was administered appeared to produce a stunning benefit for lung cancer patients. Those who received IV infusions in the morning had their cancer kept at bay for twice as long as those who got it in the afternoon, according to the results from a clinical trial in China and published in the journal Nature Medicine in February. The study also reported…

China’s Rise in Drug Development Looms Over U.S.

For decades, an annual gathering of oncologists has featured drug trials that were run mainly at American and European hospitals. But at this year’s meeting, which is being held in Chicago this weekend, the signs are everywhere of China’s ascendance as a powerhouse in drug development — and of the threat that many believe it poses to American biotechnology. The clearest sign: In what appears to be a first, one of the conference’s five coveted headliners is a presentation of a clinical trial conducted only in China. That milestone at…

American Factories Lag in Adopting A.I. This Drugmaker Is an Exception.

In a sterile Bristol Myers Squibb lab about an hour north of Boston, scientists in scrubs and hairnets transfer living cells to a 2,000-liter stainless steel bioreactor that grows them for weeks. The goal is to produce proteins that are genetically engineered to attack cells that cause disease. Tiny variations in heat, light or pH level can stop the cells from growing, causing drug shortages that endanger patients. Typically scientists would have to wait to see what went wrong during that fragile process, but now artificial intelligence is used to…